申请人:Knopp Biosciences LLC
公开号:US20190002464A1
公开(公告)日:2019-01-03
Compounds represented by formula 1 can be potent and/or partially selective for the Kv7.2/7.3 heteromultimer. They may be useful in treating disorders related to seizures, pain, neurotransmitter release, etc.